{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:11:54Z","timestamp":1778047914370,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cjca.2013.10.017","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T01:37:29Z","timestamp":1383183449000},"page":"161-172","source":"Crossref","is-referenced-by-count":16,"title":["Allosensitization in Heart Transplantation: An Overview"],"prefix":"10.1016","volume":"30","author":[{"given":"Maha A.","family":"Al-Mohaissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean A.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.10.017_bib1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mtc.2003.30","article-title":"Immunologic sensitization in recipients of left ventricular assist devices","volume":"125","author":"John","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib3","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jtcvs.2006.11.062","article-title":"Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions","volume":"133","author":"Drakos","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.2006.00509.x","article-title":"Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin","volume":"20","author":"Leech","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib5","first-page":"II294","article-title":"Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?","volume":"94","author":"Kobashigawa","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.10.017_bib6","first-page":"S120","article-title":"Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients","volume":"11","author":"Rose","year":"1992","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib7","first-page":"921","article-title":"Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation","volume":"10","author":"Lavee","year":"1991","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib8","doi-asserted-by":"crossref","first-page":"II229","DOI":"10.1161\/01.CIR.100.suppl_2.II-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.10.017_bib9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20132006","volume":"25","author":"Mehra","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.mot.0000236707.06200.17","article-title":"Clinical significance of HLA antigens and non-HLA antigens in solid organ transplantation","volume":"11","author":"Kerman","year":"2006","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib11","unstructured":"Dyer PA, Logan A, Poulton K, Wood K, Worthington J. Testing for histocompatibility. In: Forsythe J, ed. Transplantation: A Companion to Specialist Surgical Practice. Edinburgh: Saunders Company, 2009:57-69."},{"key":"10.1016\/j.cjca.2013.10.017_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jcp.2009.072371","article-title":"The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques","volume":"63","author":"Howell","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cjca.2013.10.017_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.CIR.94.2.170","article-title":"Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS\/ISHLT Thoracic Registry","volume":"94","author":"Hosenpud","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.10.017_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199403243301203","article-title":"The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study","volume":"330","author":"Opelz","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.10.017_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001573-200303000-00015","article-title":"Allosensitization in heart transplantation: implications and management strategies","volume":"18","author":"Mehra","year":"2003","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2013.10.017_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.trre.2009.07.001","article-title":"Management of allosensitized cardiac transplant candidates","volume":"23","author":"Velez","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.cjca.2013.10.017_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MAT.0b013e31826d6070","article-title":"Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome","volume":"58","author":"Urban","year":"2012","journal-title":"ASAIO J"},{"key":"10.1016\/j.cjca.2013.10.017_bib18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtcvs.2011.07.019","article-title":"Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort","volume":"142","author":"Arnaoutakis","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trre.2008.08.004","article-title":"Antibody-mediated rejection: treatment alternatives and outcomes","volume":"23","author":"Singh","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.cjca.2013.10.017_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.coi.2009.08.002","article-title":"Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways","volume":"21","author":"Li","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cjca.2013.10.017_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00595-005-3015-6","article-title":"Human leukocyte antigen antibodies for monitoring transplant patients","volume":"35","author":"Cai","year":"2005","journal-title":"Surg Today"},{"key":"10.1016\/j.cjca.2013.10.017_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.ATV.0000209501.56852.6c","article-title":"Dynamics and plasticity of Weibel-Palade bodies in endothelial cells","volume":"26","author":"Rondaij","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2013.10.017_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.coi.2009.07.010","article-title":"Management of the highly sensitized patient","volume":"21","author":"Claas","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cjca.2013.10.017_bib25","first-page":"125","article-title":"Antibodies in transplantation","volume":"10","author":"Platt","year":"2010","journal-title":"Discov Med"},{"key":"10.1016\/j.cjca.2013.10.017_bib26","unstructured":"Sykes M, Wood K, Sachs DH. Transplantation immunology. In: Paul WE, ed. Fundamental Immunology. 6th Ed. Philadelphia: Lippincott, Williams & Wilkins, 2008:1439-1441."},{"key":"10.1016\/j.cjca.2013.10.017_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.TP.0000129256.84027.D6","article-title":"Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols","volume":"78","author":"Montgomery","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1600-6143.2006.01314.x","article-title":"Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy","volume":"6","author":"Mehra","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib30","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: the Emory algorithm","volume":"6","author":"Bray","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00182069","article-title":"Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols","volume":"14","author":"Indudhara","year":"1996","journal-title":"World J Urol"},{"key":"10.1016\/j.cjca.2013.10.017_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1744-313X.2008.00800.x","article-title":"HLA antibody testing: a tool to facilitate not to prevent organ transplantation","volume":"35","author":"Claas","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.cjca.2013.10.017_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MOT.0b013e3283636c71","article-title":"Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation","volume":"18","author":"Campbell","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.healun.2012.03.016","article-title":"Prioritizing sensitized heart transplant candidates: a sensitive affair","volume":"31","author":"Kfoury","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib36","unstructured":"OPTN. Explanation of CPRA for professionals. Available at: http:\/\/www.unos.org\/docs\/CPRA_Professionals.pdf. Accessed September 30,\u00a02013."},{"key":"10.1016\/j.cjca.2013.10.017_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hfc.2007.03.003","article-title":"Understanding the sensitized patient","volume":"3","author":"Kerman","year":"2007","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2013.10.017_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.coi.2009.07.017","article-title":"Solid phase assays for HLA antibody detection in clinical transplantation","volume":"21","author":"Tait","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cjca.2013.10.017_bib39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/TP.0b013e31817c90f5","article-title":"Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients","volume":"86","author":"Fuggle","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody-mediated rejection of cardiac transplants","volume":"25","author":"Reed","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1797.2010.01414.x","article-title":"Understanding crossmatch testing in organ transplantation: a case-based guide for the general nephrologist","volume":"16","author":"Mulley","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cjca.2013.10.017_bib42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MOT.0b013e328331c169","article-title":"Utility of the virtual crossmatch in solid organ transplantation","volume":"14","author":"Amico","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.healun.2009.05.031","article-title":"Utility of virtual crossmatch in sensitized patients awaiting heart transplantation","volume":"28","author":"Stehlik","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.healun.2012.02.017","article-title":"Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program","volume":"31","author":"Chih","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00007890-200003150-00008","article-title":"Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time","volume":"69","author":"Taylor","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00746.x","article-title":"Practical application of the virtual crossmatch","volume":"11","author":"Zangwill","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib47","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/ndt\/gfn108","article-title":"Approaches for transplanting the sensitized patient: biology versus pharmacology","volume":"23","author":"Gebel","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOT.0b013e32832c433f","article-title":"Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both","volume":"14","author":"Doxiadis","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0b013e3181c9029d","article-title":"A\u00a0new UK 2006 National Kidney Allocation scheme for deceased heart-beating donor kidneys","volume":"89","author":"Johnson","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib51","unstructured":"OPTN policy 3.7. Allocation of thoracic organs. Available at: http:\/\/optn.transplant.hrsa.gov\/PoliciesandBylaws2\/policies\/pdfs\/policy_9.pdf. Accessed March 12,\u00a02013."},{"key":"10.1016\/j.cjca.2013.10.017_bib52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00007890-200209150-00014","article-title":"Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era","volume":"74","author":"Stegall","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cjca.2011.04.007","article-title":"A\u00a0successful 4S heart transplantation","volume":"27","author":"Al-Mohaissen","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.10.017_bib54","first-page":"267","article-title":"Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates","volume":"13","author":"Reinsmoen","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.cjca.2013.10.017_bib55","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.healun.2009.11.478","article-title":"Does MFI quantitation of circulating antibodies correlate with positive cytotoxicity?","volume":"29","author":"Kittleson","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humimm.2005.01.032","article-title":"Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin","volume":"66","author":"Zachary","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cjca.2013.10.017_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.TP.0000128516.82593.47","article-title":"Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation","volume":"78","author":"Gloor","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib58","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long-term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-199210000-00017","article-title":"Outcome of cardiac transplant recipients with a positive donor-specific crossmatch\u2013preliminary results with plasmapheresis","volume":"54","author":"Ratkovec","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib60","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.healun.2003.11.058","article-title":"Outcome after pre-transplant plasmapheresis for sensitized recipients awaiting heart transplantation","volume":"23","author":"Takemoto","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib61","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0041-1345(98)00172-9","article-title":"Use of intravenous immunoglobulin in sensitized LVAD recipients","volume":"30","author":"Dowling","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjca.2013.10.017_bib62","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.healun.2012.05.009","article-title":"HLA desensitization in pediatric heart transplant candidates: efficacy of rituximab and IVIg","volume":"3","author":"Schumacher","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1744-9987.1997.tb00030.x","article-title":"Plasmapheresis followed by intravenous immunoglobulin in presensitized patients awaiting thoracic organ transplantation","volume":"1","author":"Robinson","year":"1997","journal-title":"Ther Apher"},{"key":"10.1016\/j.cjca.2013.10.017_bib64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","article-title":"Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation","volume":"18","author":"Pisani","year":"1999","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib65","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.healun.2003.11.059","article-title":"The prospective use of plasmapheresis and IVIG in sensitized patients prior to heart transplantation","volume":"23","author":"Weston","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib66","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.healun.2003.11.057","article-title":"The highly sensitized patient awaiting heart transplantation: success with combination therapy of plasmapheresis and intravenous gamma globulin","volume":"23","author":"Kobashigawa","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.17.s9.3.x","article-title":"Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients","volume":"17","author":"Leech","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib68","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteosome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1010217","article-title":"Suppression of panel-reactive antibodies by treatment with mycophenolate mofetil","volume":"46","author":"Schmid","year":"1998","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib70","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/TP.0b013e3181fa93c6","article-title":"Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies","volume":"90","author":"Bu\u0107in","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib71","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/hc1002.105128","article-title":"Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients","volume":"105","author":"Itescu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.10.017_bib72","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.athoracsur.2011.04.064","article-title":"Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab","volume":"92","author":"Lick","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2215\/CJN.01651105","article-title":"Presensitization: the problem and its management","volume":"1","author":"Jordan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2013.10.017_bib74","first-page":"235","article-title":"Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients","volume":"13","author":"Jordan","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.cjca.2013.10.017_bib75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007890-199308000-00015","article-title":"Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients","volume":"56","author":"Glotz","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.10.017_bib77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transproceed.2008.10.073","article-title":"Proteasome inhibition reduces donor-specific antibody levels","volume":"41","author":"Everly","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjca.2013.10.017_bib78","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2013.10.017_bib79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7182\/prtr.19.4.tv7686631n622273","article-title":"Induction immunosuppression for orthotopic heart transplantation: a review","volume":"19","author":"Ensor","year":"2009","journal-title":"Prog Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib80","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.healun.2013.02.001","article-title":"Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data","volume":"32","author":"Kilic","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2013.10.017_bib82","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jtcvs.2012.10.034","article-title":"Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival","volume":"145","author":"Mulloy","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejcts.2008.03.062","article-title":"Myocardial tissue engineering: the extracellular matrix","volume":"34","author":"Akhyari","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2013.10.017_bib84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13016048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13016048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T06:53:58Z","timestamp":1539240838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13016048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0828282X13016048"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.10.017","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}